Cellectis S.A. Number Of Other Equity Instruments Expired In Share-based Payment Arrangement
Cellectis S.A. (CLLS) reported Number Of Other Equity Instruments Expired In Share-based Payment Arrangement of 3.08 million shares for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-20.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement · last filed 2026-03-20
pure
| Period end | Number Of Other Equity Instruments Expired In Share-based Payment Arrangement 12 month |
|---|---|
| 2018-12-31 | 35510500.00% 20-F · filed 2019-03-12 |
| 2017-12-31 | 34189100.00% 20-F · filed 2018-03-13 |
shares
| Period end | Number Of Other Equity Instruments Expired In Share-based Payment Arrangement 12 month |
|---|---|
| 2025-12-31 | 3.08M shares 20-F · filed 2026-03-20 |
| 2024-12-31 | 1.29M shares 20-F · filed 2025-03-14 |
| 2023-12-31 | 703.91K shares 20-F · filed 2024-04-29 |
| 2021-12-31 | 1.29M shares 20-F · filed 2022-03-03 |
| 2020-12-31 | 399.71K shares 20-F · filed 2021-03-04 |
| 2019-12-31 | 982.52K shares 20-F · filed 2020-03-05 |
Shares
| Period end | Number Of Other Equity Instruments Expired In Share-based Payment Arrangement 12 month |
|---|---|
| 2022-12-31 | 1.38M Shares 20-F · filed 2023-03-14 |